Number of Rotavirus (RV) Related Hospitalizations in Belgium - Season 2010-2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This study aims to confirm the statistically significant decline in rotavirus related and in acute gastro-enteritis (AGE) related hospital admissions that was observed in 11 participating hospitals, after the introduction of RV vaccines in Belgium in 2006.
| Condition | Intervention |
|---|---|
|
Rotavirus Vaccines |
Other: Data collection |
| Study Type: | Observational |
| Study Design: | Observational Model: Ecologic or Community Time Perspective: Retrospective |
| Official Title: | Assessing the Number of Rotavirus Related Hospitalizations in 11 Hospitals in Belgium - Season 2010-2011 |
- Absolute number of rotavirus related hospitalisations in children up to five years old. [ Time Frame: During the study period (from June 1st 2010 to May 31st 2011, i.e. up to 1 year) ] [ Designated as safety issue: No ]
- Classification of patients with rotavirus hospitalisation by age-group of 1-year, gender, time of the event, vaccine coverage status. [ Time Frame: During the study period (from June 1st 2010 to May 31st 2011, i.e. up to 1 year) ] [ Designated as safety issue: No ]
- The duration of rota-related hospitalisation for community acquired and nosocomial infection. [ Time Frame: During the study period (from June 1st 2010 to May 31st 2011, i.e. up to 1 year) ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 1 |
| Study Start Date: | June 2013 |
| Estimated Study Completion Date: | September 2013 |
| Estimated Primary Completion Date: | September 2013 (Final data collection date for primary outcome measure) |
| Groups/Cohorts | Assigned Interventions |
|---|---|
|
Group A
All children ≤ 5 years old with a rotavirus detection test (inpatient and ambulatory tests) performed during the period of June the 1st 2010 and May the 31st 2011.
|
Other: Data collection
Each participating centre will be requested to generate a coded list of all stool samples taken during the study period (June 1st 2010- May 31st 2011) and analysed for rotavirus, in children aged ≤5 years.
|
Detailed Description:
This retrospective study will use anonymised data, extracted from hospital databases during the period of the 1st of June 2010 until the 31st of May 2011. IMS Health sales data will be used to provide rotavirus vaccine coverage estimates (Rotarix and Rotateq) for the Belgian population during the study period. Any additional source of vaccine coverage status describing rotavirus vaccine uptake in the study population will also be reported.
Eligibility| Ages Eligible for Study: | up to 5 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Children aged ≤5 years undergoing a RV detection test across 11 participating hospitals.
Inclusion Criteria:
- Child aged ≤5 years;
- A stool sample has been provided for a rotavirus detection test during the study period;
- Laboratory test result of rotavirus is available.
Exclusion Criteria:
Not applicable.
Contacts and Locations| Contact: US GSK Clinical Trials Call Center | 877-379-3718 | GSKClinicalSupportHD@gsk.com |
| Study Director: | GSK Clinical Trials | GlaxoSmithKline |
More Information
No publications provided
| Responsible Party: | GlaxoSmithKline |
| ClinicalTrials.gov Identifier: | NCT01563159 History of Changes |
| Other Study ID Numbers: | 116312 |
| Study First Received: | March 1, 2012 |
| Last Updated: | April 5, 2013 |
| Health Authority: | Belgium: Ministry of Health |
Keywords provided by GlaxoSmithKline:
|
Belgium hospitals Rotavirus |
ClinicalTrials.gov processed this record on June 13, 2013